臨床試験を検索:amendement du facteur C5 du complément
合計371377件
-
University of CincinnatiUniversity of Colorado, Denver; Children's Hospital Medical Center, Cincinnati完了
-
University of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI); GlaxoSmithKline完了
-
National Heart, Lung, and Blood Institute (NHLBI)完了心臓疾患 | 心血管疾患 | アテローム性動脈硬化症 | 冠動脈硬化症
-
National Heart, Lung, and Blood Institute (NHLBI)完了
-
National Heart, Lung, and Blood Institute (NHLBI)完了
-
Centre Hospitalier Universitaire Vaudois完了
-
United Therapeutics完了
-
AOP Orphan Pharmaceuticals AGPharmaEssentia Corporation (Co-Sponsor for USA)完了真性赤血球増加症オーストリア, ブルガリア, チェコ共和国, フランス, ハンガリー, ポーランド, スロバキア, ウクライナ
-
Memorial Sloan Kettering Cancer CenterAmgen終了しました
-
Heart Force Medical Inc.完了
-
Gustave Roussy, Cancer Campus, Grand Parisわからない
-
Göteborg UniversityVastra Gotaland Region; Vinnova完了
-
Japan Blood Products Organization完了
-
Posit Science CorporationUniversity of California, San Francisco; Case Western Reserve University引きこもった
-
Fundación para la Investigación del Hospital Clínico...Ministerio de Sanidad, Servicios Sociales e Igualdad完了
-
Astellas Pharma IncAstellas Pharma Taiwan, Inc.完了
-
University of Wisconsin, MadisonOcean Spray Cranberries, Inc.完了
-
Centre Hospitalier Universitaire VaudoisGlaxoSmithKline; University of Lausanne; University of Lausanne Hospitals; World Health Organization と他の協力者完了
-
Helsinn Healthcare SA完了
-
Dompé Farmaceutici S.p.A完了
-
Zhejiang Cancer Hospitalわからない
-
Logan University, Inc.Sport and Spine Rehab Clinical Research Foundation; Parker University; Brentwood Spine Clinic,...終了しました
-
Beijing Center for Disease Control and PreventionBeijing Minhai Biotechnology Co., Ltd完了健康 | 狂犬病
-
University of CincinnatiGenzyme, a Sanofi Company; Millennium Pharmaceuticals, Inc.完了
-
Beijing Chaoyang District Centre for Disease Control...完了
-
Beijing Center for Disease Control and PreventionBeijing Minhai Biotechnology Co., Ltd完了安全性、免疫原性
-
University of PittsburghNational Cancer Institute (NCI)完了
-
Mount Sinai Hospital, Canada完了